Big Movers: Lake Shore Gold Corp. (NYSEMKT:LSG), Tidewater Inc. (NYSE:TDW), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), SunEdison, Inc. (NYSE:SUNE), DBV Technologies S.A. (NASDAQ:DBVT)

On 24 February, Lake Shore Gold Corp. (NYSEMKT:LSG) reported Record revenue of $271.4 million ($61.7 million in Q4/15). Record cash earnings from mine operations of $136.6 million ($27.9 million in Q4/15). Net earnings of $8.7 million or $0.02 per common share (net loss of $4.5 million or $0.01 per common share in Q4/15).

Lake Shore Gold Corp. (NYSEMKT:LSG) belongs to Basic Materials sector. Its weekly performance is 6.15%. On last trading day company shares ended up at $1.38. Lake Shore Gold Corp. (NYSEMKT:LSG) distance from 50-day simple moving average (SMA50) is 37.12%.

On 1st March, Tidewater Inc. (NYSE:TDW) announced that the annulment committee formed by the World Bank’s International Centre for the Settlement of Investment Disputes (“ICSID”) ruled that subsidiaries of the company are free to pursue the enforcement of a portion of a prior arbitration award against the Bolivarian Republic of Venezuela (“Venezuela”). That portion amounts to $37.2 million after including interest from the date of the expropriation by Venezuela (May 8, 2009).

Tidewater Inc. (NYSE:TDW) shares increased 27.58% in last trading session and ended the day at $9.90. TDW Gross Margin is 39.30% and its return on assets is -1.90%. Tidewater Inc. (NYSE:TDW) quarterly performance is 13.27%.

On 1st March, Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) announced results of new data showing that EXPAREL® (bupivacaine liposome injectable suspension) infiltration compared to a standard analgesic regimen in patients undergoing total knee arthroplasty (TKA) significantly decreased the length of hospital stay and increased the likelihood that a patient would be discharged to their home rather than a care facility when released from the hospital.

On 04 March, Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) shares remains unchanged and was closed at $54.25. PCRX EPS growth in last 5 year was 15.20%. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) year to date (YTD) performance is -29.35%.

SunEdison, Inc. (NYSE: SUNE) announced that it has suspended payment of quarterly dividends on the Company’s 6.75% Series A Perpetual Convertible Preferred Stock. Dividends on the Perpetual Convertible Preferred Stock are payable in cash or common stock (with a floor price of $7.34) and suspended dividends will accumulate in arrears. The Company’s Board of Directors intends to reassess its dividend policy on an ongoing basis.

SunEdison, Inc. (NYSE:SUNE) ended the last trading day at $1.78. Company weekly volatility is calculated as 22.11% and price to cash ratio as 0.24. SunEdison, Inc. (NYSE:SUNE) showed a weekly performance of -21.24%.

DBV Technologies (NASDAQ: DBVT) announced the presentation of results from CoFAR6, a Consortium of Food Allergy Research (CoFAR) study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), showing that treatment with Viaskin® Peanut was observed to be safe and well-tolerated, and led to statistically significant desensitization in trial subjects. The 52-week CoFAR6 results were highlighted during two oral presentations at the 2016 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Los Angeles, CA.

DBV Technologies S.A. (NASDAQ:DBVT) shares increased 3.48% in last trading session and ended the day at $26.15. DBV Technologies S.A. (NASDAQ:DBVT) quarterly performance is -24.20%.

Leave a Reply

Your email address will not be published. Required fields are marked *